Prism Medico and Pharmacy Limited (BOM:512217)

Prism Medico and Pharmacy Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Apr 1, 2023	Apr 1, 2022	Apr 1, 2021
Operating Revenue	21.58	6.32	29.25	12.71	84.44	167.64
Other Revenue	-	-	0	-	0	-
Revenue	21.58	6.32	29.25	12.71	84.44	167.64
Revenue Growth (YoY)	-27.78%	-78.40%	130.21%	-84.95%	-49.63%	-37.66%
Cost of Revenue	12.58	4.49	25.61	11.41	86.28	166.68
Gross Profit	9	1.83	3.65	1.3	-1.84	0.96
Selling, General & Admin	2.59	2.6	5.02	2.27	3.06	2.58
Other Operating Expenses	-0.39	-0.08	-0.61	-0.02	-	-
Operating Expenses	2.24	2.56	4.46	2.32	3.15	2.7
Operating Income	6.76	-0.73	-0.82	-1.02	-4.99	-1.75
Interest Expense	-0.01	-	-	-0	-0.01	-
Interest & Investment Income	-	-	0	-	-	-
Currency Exchange Gain (Loss)	-	0.09	0.6	-	-	-
Other Non Operating Income (Expenses)	-0	-0.02	-0.07	-0	0	-0
EBT Excluding Unusual Items	6.74	-0.66	-0.29	-1.02	-4.99	-1.75
Pretax Income	6.74	-0.66	-0.28	-1.02	-4.99	-1.75
Income Tax Expense	-0.24	-0.17	-0.07	-0.26	-1.29	-0.45
Net Income	6.99	-0.49	-0.21	-0.76	-3.7	-1.3
Net Income to Common	6.99	-0.49	-0.21	-0.76	-3.7	-1.3
Shares Outstanding (Basic)	-	6	6	6	6	6
Shares Outstanding (Diluted)	-	6	6	6	6	6
Shares Change (YoY)	-	-	3.31%	-3.21%	0.01%	-
EPS (Basic)	-	-0.08	-0.04	-0.13	-0.61	-0.21
EPS (Diluted)	-	-0.08	-0.04	-0.13	-0.61	-0.21
Gross Margin	41.70%	29.02%	12.46%	10.23%	-2.18%	0.57%
Operating Margin	31.31%	-11.54%	-2.80%	-8.01%	-5.90%	-1.04%
Profit Margin	32.37%	-7.71%	-0.73%	-6.00%	-4.38%	-0.78%
EBITDA	6.8	-0.69	-0.77	-0.95	-4.9	-1.63
EBITDA Margin	31.50%	-10.87%	-2.61%	-7.49%	-5.80%	-0.97%
D&A For EBITDA	0.04	0.04	0.05	0.07	0.09	0.12
EBIT	6.76	-0.73	-0.82	-1.02	-4.99	-1.75
EBIT Margin	31.31%	-11.54%	-2.80%	-8.01%	-5.90%	-1.04%
Revenue as Reported	21.73	6.48	30.48	12.72	84.44	167.64
Advertising Expenses	-	0.17	0.34	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.